BioStem Technologies Net Profit Margin Growth & History (BSEM)
BioStem Technologies's net profit margin was 0.00% for fiscal 2025.
View full BioStem Technologies company overviewBioStem Technologies annual net profit margin history
| Fiscal year | Period ended | Net profit margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 0.00% | 0.00 pp |
| 2024 | 2024-12-31 | 0.00% | +50.84 pp |
| 2023 | 2023-12-31 | −50.84% | +53.78 pp |
| 2022 | 2022-12-31 | −104.62% | −71.32 pp |
| 2021 | 2021-12-31 | −33.30% | — |
BioStem Technologies quarterly net profit margin
| Fiscal quarter | Period ended | Net profit margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −113.57% | −113.67 pp |
| Q1 2026 | 2026-03-31 | 0.00% | +0.00 pp |
| Q3 2025 | 2025-09-30 | 7.27% | — |
| Q2 2025 | 2025-06-30 | 0.10% | — |
| Q1 2025 | 2025-03-31 | 0.00% | — |
| Q4 2024 | 2024-12-31 | 15.09% | — |
BioStem Technologies net profit margin trends
Between the periods ended 2021-12-31 and 2025-12-31, BioStem Technologies's net profit margin increased from −33.30% to 0.00%, a change of +33.30 percentage points. The latest reported quarter, Q2 2026, shows −113.57%.
What net profit margin means
Net profit margin measures the percentage of revenue remaining as net income after operating costs, interest, taxes, and other expenses. It shows how much bottom-line profit or loss a company generates from each dollar of revenue.
How net profit margin is calculated
TickerStat calculates net profit margin as SEC-reported net income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review BioStem Technologies source filings ↗